Bristol Myers Squibb to Participate in Citi’s 17th Annual BioPharma Conference
Bristol Myers Squibb (NYSE: BMY) will participate in Citi’s 17th Annual BioPharma Conference on September 8, 2022, in Boston, Massachusetts. The session is scheduled for 8:50 a.m. ET, where company executives will address questions regarding the firm. Investors and the public can listen to a live webcast of the event on BMS.com, with an archived version available later the same day. Bristol Myers Squibb is dedicated to developing innovative medicines to combat serious diseases.
- None.
- None.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About
corporatefinancial-news
View source version on businesswire.com: https://www.businesswire.com/news/home/20220831005061/en/
Media:
media@bms.com
Investor Relations:
investor.relations@bms.com
Source:
FAQ
What conference is Bristol Myers Squibb participating in on September 8, 2022?
What time is Bristol Myers Squibb's session at the BioPharma Conference?
How can I listen to Bristol Myers Squibb's session at the conference?
Will Bristol Myers Squibb's conference session be available later?